PL1670773T3 - Sposób wytwarzania sulfonamidów benzoksazolu i ich związków pośrednich - Google Patents
Sposób wytwarzania sulfonamidów benzoksazolu i ich związków pośrednichInfo
- Publication number
- PL1670773T3 PL1670773T3 PL04766869T PL04766869T PL1670773T3 PL 1670773 T3 PL1670773 T3 PL 1670773T3 PL 04766869 T PL04766869 T PL 04766869T PL 04766869 T PL04766869 T PL 04766869T PL 1670773 T3 PL1670773 T3 PL 1670773T3
- Authority
- PL
- Poland
- Prior art keywords
- intermediates
- preparation
- methods
- sulfonamide compounds
- benzoxazole sulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03103630 | 2003-09-30 | ||
| US50799603P | 2003-10-02 | 2003-10-02 | |
| EP04766869A EP1670773B1 (en) | 2003-09-30 | 2004-09-30 | Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
| PCT/EP2004/052382 WO2005030739A1 (en) | 2003-09-30 | 2004-09-30 | Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1670773T3 true PL1670773T3 (pl) | 2007-06-29 |
Family
ID=34395298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04766869T PL1670773T3 (pl) | 2003-09-30 | 2004-09-30 | Sposób wytwarzania sulfonamidów benzoksazolu i ich związków pośrednich |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070123574A1 (pl) |
| EP (1) | EP1670773B1 (pl) |
| JP (1) | JP4919802B2 (pl) |
| KR (1) | KR101090102B1 (pl) |
| CN (1) | CN1860107B (pl) |
| AP (1) | AP1985A (pl) |
| AT (1) | ATE353323T1 (pl) |
| AU (1) | AU2004276017B2 (pl) |
| BR (1) | BRPI0414916A (pl) |
| CA (1) | CA2537877C (pl) |
| DE (1) | DE602004004674T2 (pl) |
| DK (1) | DK1670773T3 (pl) |
| EA (1) | EA011891B1 (pl) |
| ES (1) | ES2281828T3 (pl) |
| IL (1) | IL173891A0 (pl) |
| IN (1) | IN2012DN02301A (pl) |
| MX (1) | MXPA06003575A (pl) |
| NO (1) | NO20061951L (pl) |
| NZ (1) | NZ546279A (pl) |
| PL (1) | PL1670773T3 (pl) |
| PT (1) | PT1670773E (pl) |
| SI (1) | SI1670773T1 (pl) |
| WO (1) | WO2005030739A1 (pl) |
| ZA (1) | ZA200602603B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR053845A1 (es) * | 2005-04-15 | 2007-05-23 | Tibotec Pharm Ltd | 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450 |
| US8575186B2 (en) | 2009-10-05 | 2013-11-05 | Albany Molecular Research, Inc. | Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof |
| WO2012099952A2 (en) | 2011-01-19 | 2012-07-26 | Albany Molecular Research, Inc. | Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia |
| WO2014194519A1 (en) | 2013-06-07 | 2014-12-11 | Merck Sharp & Dohme Corp. | Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968942A (en) * | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| JP4124818B2 (ja) * | 1995-03-10 | 2008-07-23 | ジー．ディー．サール アンド カンパニー | ヘテロシクロカルボニルアミノ酸ヒドロキシエチルアミノスルホンアミドレトロウイルスプロテアーゼインヒビター |
| AU7722296A (en) * | 1995-11-15 | 1997-06-05 | G.D. Searle & Co. | Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| JP4008708B2 (ja) * | 2000-04-07 | 2007-11-14 | サムスン エレクトロニクス カンパニー リミテッド | マトリックスメタロプロテイナーゼの阻害剤としてのスルホンアミド誘導体 |
| US6455738B1 (en) * | 2000-07-13 | 2002-09-24 | Rhodia Chimie | Process for the sulfonation of an aromatic compound |
| DE60215623T2 (de) * | 2001-02-14 | 2007-08-30 | Tibotec Pharmaceuticals Ltd. | Breitspektrum 2-(substituierte-amino)-benzothiazol-sulfonamide hiv protease inhibitoren |
| EP1387842B1 (en) * | 2001-05-11 | 2009-04-22 | Tibotec Pharmaceuticals Ltd. | Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| AR037797A1 (es) * | 2001-12-12 | 2004-12-01 | Tibotec Pharm Ltd | Combinacion de inhibidores de proteasa dependientes del citocromo p450 |
| MY142238A (en) * | 2002-03-12 | 2010-11-15 | Tibotec Pharm Ltd | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
-
2004
- 2004-09-30 JP JP2006530265A patent/JP4919802B2/ja not_active Expired - Fee Related
- 2004-09-30 EA EA200600699A patent/EA011891B1/ru not_active IP Right Cessation
- 2004-09-30 CN CN2004800280971A patent/CN1860107B/zh not_active Expired - Fee Related
- 2004-09-30 IN IN2301DEN2012 patent/IN2012DN02301A/en unknown
- 2004-09-30 KR KR1020067005992A patent/KR101090102B1/ko not_active IP Right Cessation
- 2004-09-30 AT AT04766869T patent/ATE353323T1/de active
- 2004-09-30 EP EP04766869A patent/EP1670773B1/en active Active
- 2004-09-30 AU AU2004276017A patent/AU2004276017B2/en not_active Ceased
- 2004-09-30 AP AP2006003603A patent/AP1985A/xx active
- 2004-09-30 WO PCT/EP2004/052382 patent/WO2005030739A1/en active IP Right Grant
- 2004-09-30 PL PL04766869T patent/PL1670773T3/pl unknown
- 2004-09-30 MX MXPA06003575A patent/MXPA06003575A/es active IP Right Grant
- 2004-09-30 ES ES04766869T patent/ES2281828T3/es active Active
- 2004-09-30 DE DE602004004674T patent/DE602004004674T2/de active Active
- 2004-09-30 BR BRPI0414916-5A patent/BRPI0414916A/pt not_active IP Right Cessation
- 2004-09-30 US US10/574,157 patent/US20070123574A1/en not_active Abandoned
- 2004-09-30 CA CA2537877A patent/CA2537877C/en not_active Expired - Fee Related
- 2004-09-30 PT PT04766869T patent/PT1670773E/pt unknown
- 2004-09-30 SI SI200430265T patent/SI1670773T1/sl unknown
- 2004-09-30 DK DK04766869T patent/DK1670773T3/da active
- 2004-09-30 NZ NZ546279A patent/NZ546279A/en not_active IP Right Cessation
-
2006
- 2006-02-22 IL IL173891A patent/IL173891A0/en not_active IP Right Cessation
- 2006-03-29 ZA ZA200602603A patent/ZA200602603B/xx unknown
- 2006-05-02 NO NO20061951A patent/NO20061951L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004004674D1 (de) | 2007-03-22 |
| JP4919802B2 (ja) | 2012-04-18 |
| CN1860107A (zh) | 2006-11-08 |
| IL173891A0 (en) | 2006-07-05 |
| ZA200602603B (en) | 2008-05-28 |
| AP2006003603A0 (en) | 2006-04-30 |
| EA011891B1 (ru) | 2009-06-30 |
| DE602004004674T2 (de) | 2007-11-22 |
| NO20061951L (no) | 2006-05-02 |
| DK1670773T3 (da) | 2007-05-29 |
| US20070123574A1 (en) | 2007-05-31 |
| CA2537877A1 (en) | 2005-04-07 |
| AU2004276017B2 (en) | 2010-08-19 |
| MXPA06003575A (es) | 2006-06-05 |
| AU2004276017A1 (en) | 2005-04-07 |
| IN2012DN02301A (pl) | 2015-08-14 |
| BRPI0414916A (pt) | 2006-11-07 |
| KR101090102B1 (ko) | 2011-12-07 |
| CA2537877C (en) | 2015-03-17 |
| ES2281828T3 (es) | 2007-10-01 |
| EP1670773A1 (en) | 2006-06-21 |
| JP2007507468A (ja) | 2007-03-29 |
| AP1985A (en) | 2009-03-30 |
| EP1670773B1 (en) | 2007-02-07 |
| NZ546279A (en) | 2008-09-26 |
| EA200600699A1 (ru) | 2006-08-25 |
| KR20060092224A (ko) | 2006-08-22 |
| SI1670773T1 (sl) | 2007-06-30 |
| WO2005030739A1 (en) | 2005-04-07 |
| CN1860107B (zh) | 2013-08-21 |
| ATE353323T1 (de) | 2007-02-15 |
| PT1670773E (pt) | 2007-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR8226A (es) | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos | |
| ZA200605348B (en) | Solid forms of anti-EGFR-antibodies | |
| HK1108157A1 (en) | Intermediates for the preparation of dioxane-2-alkyl carbamates | |
| ZA200509103B (en) | Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamideor salts thereof | |
| HK1116800A1 (en) | Arylvinylazacycloalkane compounds and methods of preparation and use thereof | |
| SI1587542T1 (sl) | Uporaba anti-cd100 protiteles | |
| ZA200601991B (en) | Process for the preparation of renzapride and intermediates thereof | |
| DK1546122T3 (da) | Fremgangsmåde til fremstilling af valsartan | |
| NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
| EP1633749A4 (en) | DEAZAFLAVIN COMPOUNDS AND METHODS OF USE | |
| ZA200602603B (en) | Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof | |
| ITMI20031994A1 (it) | Procedimento per la preparazione di fludarabina fosfato | |
| ITMI20030018A1 (it) | Procedimento per la preparazione di composti mono- | |
| SI1622926T1 (sl) | Nov postopek in intermediati za pripravo 17-halogen-19-nor-steroidnih spojin | |
| ITMI20030019A1 (it) | Procedimento per la preparazione di composti mono- | |
| ITMI20041086A1 (it) | Procedimento per la preparazione di idrocarbilalogenuri | |
| ITIS20030007A1 (it) | Procedimento per la preparazione di cefalosporine | |
| ITMI20020620A1 (it) | Procedimento per la preparazione di alchil-benzoati per esterificazione di benzoil-fluoruri | |
| FI20031420A (fi) | Menetelmä uusien 7-substituoitu-9-(substituoitu amino)-6-demetyyli-6-deoksitetrasykliinien valmistamiseksi | |
| IL201472A0 (en) | Intermediates for the preparation of dioxane-2-alkyl carbamates | |
| ITPD20030178A1 (it) | Procedimento per la preparazione di lastre | |
| NO20044424L (no) | Fremgangsmate for fremstilling av sertindol | |
| ITMI20031223A0 (it) | Procedimento per la preparazione di cloro-ortoesteri alifatici | |
| ITVA20020048A1 (it) | Procedimento per la realizzazione di componenti di | |
| NO20054977D0 (no) | Fremgangsmate for fremstilling av imidazopyridin-8-oner |